Researchers at the Beijing Institute of Genomics (BIG) have been to Fiocruz for the Brazil-China seminar on Bioinformatics, Big Data and Precision Medicine.
The activity was promoted by the Bioinformatics Center of the National Laboratory of Scientific Computation (LNCC), in partnership with Fiocruz, the National Institute for Cancer (Inca) and the Federal University of Rio de Janeiro (UFRJ).
At the time, Chinese and Brazilian scientists presented their research and discoveries in several areas of computing with application of large databases in life sciences, especially the area of Genomics, Bioinformatics and Precision Medicine.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze